This is an old revision of this page, as edited by Pashihiko (talk | contribs) at 06:33, 20 January 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 06:33, 20 January 2011 by Pashihiko (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.427  |
| Chemical and physical data | |
| Formula | C16H22N4O4 |
| Molar mass | 334.70 g/mol g·mol |
| 3D model (JSmol) | |
SMILES
| |
Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.
References
- Aschhoff HS, Vergin H (1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother. 5 (B): 19–25. PMID 43863.
{{cite journal}}: Unknown parameter|month=ignored (help)
 | This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |
| Antibacterials that inhibit nucleic acid (J01E, J01M) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
| Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
| ||||||||||||||||
| Anaerobic DNA inhibitors |
| ||||||||||||||||
| RNA synthesis |
| ||||||||||||||||
| |||||||||||||||||